Using SnapshotNIR With Provocative Leg Maneuver for PAD Assessment - Trial NCT06237621
Access comprehensive clinical trial information for NCT06237621 through Pure Global AI's free database. This phase not specified trial is sponsored by Kent Imaging Inc and is currently Recruiting. The study focuses on Peripheral Arterial Disease. Target enrollment is 150 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Kent Imaging Inc
Timeline & Enrollment
N/A
Jan 01, 2024
Jun 01, 2025
Primary Outcome
Comparing change in plantar foot NIRS measurements (baseline vs raised position) during a Provocative Maneuver Leg Raise test to the SOC clinical assessment of PAD
Summary
The objective of this trial is to determine if Near-infrared spectroscopy (NIRS) can
 accurately evaluate the degree of Peripheral Arterial Disease (PAD) during a Provocative
 Elevation Maneuver of the Lower Extremity (PEMLE) test, as compared to routine clinical
 assessments.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06237621
Device Trial